Endoscope Reprocessing Market

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, AER (Portable, Standalone), Endoscope Tracking Solutions, Endoscope Drying, Storage, & Transport Systems), End User (Hospitals, ASCs & Clinics) - Global Forecast to 2026

Report Code: MD 5654 Jul, 2021, by marketsandmarkets.com

[241 Pages Report] The endoscope reprocessing market is projected to reach USD 3.2 billion by 2026 from USD 2.1 billion in 2021, at a CAGR of 9.0% from 2021 to 2026. The increasing preference for endoscopic procedures, high risk of endoscope-associated infections, growing geriatric population and the subsequent increase of endoscopic procedures, and increasing emphasis on improving reprocessing guidelines by healthcare facilities in the market during the forecast period.

Endoscope Reprocessing Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID -19 Impact On The Endoscope Reprocessing Market

The rapid spread of COVID-19 previously forced the postponement of elective endoscopic procedures and non-essential GI office activity. Due to the outbreak of COVID, the risk of infection resulting from improper reprocessing of endoscopes is a rising concern among leaders in pulmonology and otolaryngology. The SARS-CoV-2 virus has a lipid envelope structure that makes it more resistant to cleaning by enzymatic detergents. Endoscopes must be disinfected, according to manufacturer IFUs, after pre-cleaning by detergent. Due to the resistance of the virus to pre-cleaning, it decreases the safety margin to achieve appropriate HLD.

Besides, there is a high risk of transmission of the COVID-19 virus during endoscopy surgery. Various countries have penned down several guidelines to keep all non-emergent surgeries on halt. As per the results of an international survey published in PubMed, 85% of the countries out of the 48 participating countries decreased procedure volume by over 50%, and four endoscopy units (2.45%) completely stopped. Owing to COVID, various GI endoscopy centers had a significant reduction in their volume and most procedures performed were urgent.

In addition, companies have registered a decline in their revenue in the first quarter of 2020, primarily due to COVID 19. For instance, a press release of Cantel Medical stated that first-quarter 2021 net sales were USD 297.0 Mn, up 15.5% compared to the prior year. Excluding the impact from foreign currency, net sales increased by 14.7%, primarily driven by the impact from acquisitions of 16.5%, offset by an organic decline of 1.8%. The decline in organic sales was largely the result of the reduction of elective procedures driven by the worldwide COVID pandemic, which impacted the Company's entire first quarter. The above-mentioned factors are expected to marginally affect the growth of endoscope reprocessing market.

Market Dynamics

Driver: High risk of endoscope-associated infections

Endoscope-associated infections due to contaminated endoscopes continue to be reported worldwide. Although endoscope-associated infections are, duodenoscope-related, recent reports also discuss outbreaks related to gastroscopes, colonoscopes, and bronchoscopes. Despite adequate measures to conduct the reprocessing of endoscopes, cases of infections caused due to the use of endoscopes have been significantly high.

Recent studies have assessed duodenoscope contamination incidence rates ranging from 0.3% to 30%, although linear echoendoscopes with a similar complex design, gastroscope, and colonoscopes can also be contaminated. Klebsiella pneumoniae and Pseudomonas aeruginosa are frequently involved in endoscopy-related outbreaks, probably due to their persistence in biofilms. Subject to heavy wear and tear, damaged parts such as biopsy channels are vulnerable to biofilm formation.

Such infections, which occur due to improper sterilization, are compelling stakeholders in the healthcare industry to undertake several initiatives to reduce the risk of infections for patients. For instance, in May 2015, the FDA recommended that by 2018, flexible scopes be defined as critical devices, which would require mandated sterilization (versus their status as semi-critical devices, which only require disinfection). Such initiatives are expected to increase the demand for endoscope reprocessing products in the coming years.

Restraints: High cost of endoscopy procedures and limited reimbursements in developing countries

The average price of an automated endoscope reprocessor is about USD 6,000-7,000. Healthcare providers, particularly in developing countries such as India, Brazil, and Mexico, have low financial resources to invest in such costly sophisticated technologies. Moreover, for the efficient handling and maintenance of endoscopy systems and equipment, appropriate training needs to be provided to the staff. Maintaining endoscopy equipment is of vital importance as improperly reprocessed endoscopes can lead to cross-contamination and can potentially expose patients to infections. This can further add up to the already high medical bills for endoscopy. In addition, constant heating and cooling during disinfection procedures lead to wear and tear of the insertion and light guide tubes, which can hamper the durability of the equipment.

Owing to the high capital, training, and maintenance costs, the cost of endoscopy procedures is high. For instance, the average cost of a colonoscopy procedure is around USD 1,000 in many developing countries, which is like the cost in developed countries. The reprocessing process is complex, time-consuming, and costly, which has led to a focus on single-use endoscopes. As per a study published in 2017, the cost associated with reprocessing endoscopes is staggering; from USD 114.07 to USD 280.71 for one endoscope.

Also, there is limited or no reimbursement for endoscopy procedures in these countries. The cost of endoscopy procedures in the US, which is the largest market for endoscopy products, is USD 1,000-1,500. Such cost- and reimbursement-related issues are expected to limit the adoption of endoscopy procedures among potential customers.

Opportunity: Growing medical devices industry in emerging economies

Emerging economies such as India, China, Brazil, Russia, and countries in Latin America and Southeast Asia are expected to provide significant growth opportunities to players operating in the endoscope reprocessing market. Over half the world’s population resides in India and China, making these markets home to a large patient population. Public pressure to improve the quality of hospital care, the increased cost of HAIs in healthcare systems, the emergence of multi-drug-resistant microorganisms, and the initiatives of government authorities are playing an important role in the growth of the market in these countries.

With growth in the per capita income and increased awareness, the growing number of hospitals and clinics, and the vast patient population, the demand for better quality healthcare services has increased in these countries. Besides, many developed countries consider emerging countries as a cost-saving hub and invest heavily in R&D and the manufacturing of medical devices and new drugs in these countries, which drives the medical device markets.

Emerging economies in the APAC region present lucrative investment opportunities for multinational infection control companies to offshore their business operations to these markets. For instance, in September 2018, Ecolab inaugurated the Greater China Healthcare Innovation and Customer Experience Center in Shanghai. In October 2017, the company expanded its presence across the APAC region by establishing new headquarters in Singapore. Expansions in emerging markets are driving the uptake of endoscope reprocessing products in the medical device manufacturing industry in these countries, thereby providing growth opportunities for the product manufacturers and service providers.

“High-level disinfectants and test strips are expected to hold the largest share of the endoscope reprocessing market, by product in 2021.”

Based on product, the global endoscope reprocessing market is segmented into high-level disinfectants and test strips; detergents & wipes; endoscope tracking systems; endoscope drying, storage, and transport systems; automated endoscope reprocessors (AERs); and other products (brushes and flushing aids, leak testers, hookups, and sponges). In 2020, the high-level disinfectants and test strips segment accounted for the largest share of the global endoscope reprocessing market. The large share of this segment can be attributed to the increasing outbreaks linked to inadequate cleaning or disinfecting during HLD, the effectiveness of high-level disinfectants for quality assurance in decontaminating endoscopes, and rising adherence to endoscope reprocessing guidelines by healthcare centers.

“Hospitals are expected to hold the largest share of the endoscope reprocessing market, by end user in 2021.”

Based on end users, the global endoscope reprocessing market is segmented into hospitals, ambulatory surgery centers and clinics, and other end users (diagnostic centers, mobile endoscopy facilities, and office endoscopy centers). In 2020, the hospitals' segment accounted for the largest share owing to the increasing government & private funding, growth in the healthcare sector in emerging economies, increasing out-of-pocket healthcare expenditure worldwide, and the increasing number of endoscopic procedures performed.

Endoscope Reprocessing Market by Region

To know about the assumptions considered for the study, download the pdf brochure

“North America commanded the largest share of the endoscope reprocessing market in 2021.”

Based on region, the endoscope reprocessing market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2020, North America commanded the largest share of the endoscope reprocessing market. The largest share of North America can be attributed to factors such as the rising incidence of cancer, favorable reimbursement scenarios, and increasing incidence of endoscope-related infections.

Key Market Players

The major players operating in this market are Cantel Medical (US), Advanced Sterilization Products (ASP) (US), Olympus Corporation (Japan), Ecolab (US), STERIS (Ireland), Getinge AB (Sweden), Wassenburg Medical (Netherlands), CONMED Corporation (US), Belimed AG (Switzerland), Endo-Technik W. Griesat (Germany), Custom Ultrasonics (US), Steelco S.p.A. (Italy), BES Healthcare Ltd (UK), ARC Healthcare Solutions (Canada), Metrex Research, LLC. (Canada), Richard Wolf GmbH (Germany), MEDALKAN (Greece), Micro-Scientific, LLC (US), Borer Chemie AG (Switzerland), Tuttnauer (Netherlands), ATMS (Canada), Summit Imaging, Inc. (US), Medonica Co. LTD (South Korea), SHINVA MEDICAL INSTRUMENT CO. LTD (China), and Medical Devices Group Srl (Italy).

Scope of the Report

Report Metric

Details

Market Size Available for Years

2017–2026

Base Year Considered

2020

Forecast Period

2021–2026

Forecast Units

Value (USD Billion)

Segments Covered

Product, end user, and region

Geographies Covered

North America (US and Canada), Europe (Germany, France, UK, Italy, Spain, and the RoE), APAC (Japan, China, India, and the RoAPAC), and Rest of the World (RoW) (Middle East & Africa and Latin America)

Companies Covered

Cantel Medical (US), Advanced Sterilization Products (ASP) (US), Olympus Corporation (Japan), Ecolab (US), STERIS (Ireland), Getinge AB (Sweden), Wassenburg Medical (Netherlands), CONMED Corporation (US), Belimed AG (Switzerland), Endo-Technik W. Griesat (Germany), Custom Ultrasonics (US), Steelco S.p.A. (Italy), BES Healthcare Ltd (UK), ARC Healthcare Solutions (Canada), Metrex Research, LLC. (Canada), Richard Wolf GmbH (Germany), MEDALKAN (Greece), Micro-Scientific, LLC (US), Borer Chemie AG (Switzerland), Tuttnauer (Netherlands), ATMS (Canada), Summit Imaging, Inc. (US), Medonica Co. LTD (South Korea), SHINVA MEDICAL INSTRUMENT CO. LTD (China), and Medical Devices Group Srl (Italy).

This research report categorizes the endoscope reprocessing market into the following segments and subsegments:

Endoscope Reprocessing Market by Product

  • High-Level Disinfectants and Test Strips
  • Detergents & Wipes
  • Automated Endoscope Reprocessors
    • AER, by Type
      • Single-basin AER
      • Double-basin AER
    • AER, by Portability
      • Standalone AER
      • Portable AER
  • Endoscope Drying, Storage, & Transport Systems
  • Endoscope Tracking Solutions
  • Other Products

Endoscope reprocessing Market by End User

  • Hospitals
  • Ambulatory Surgical Centers and Clinics
  • Other End Users

Endoscope reprocessing Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • sia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Rest of the World
    • Latin America
    • Middle East & Africa

Key developments:

  • In 2021, Getinge partnered with researchers from the School of Business, Economics and Law at the University of Gothenburg, Sweden, on customer-centric innovation and sustainability. This will help the company gain access to the researchers’ socially relevant and applicable knowledge.
  • In 2021, Getinge opened a new Customer Experience Center to interact with and support customers.
  • In 2020, STERIS entered into a definitive agreement to acquire Cantel through a US subsidiary. The acquisition will enable STERIS to offer a broader set of Customers a more diversified selection of infection prevention and procedural products and services.
  • In 2020, Olympus Corporation launched OER-Elite.
  • In 2019, Advanced Sterilization Products’ ASP AEROFLEX Automatic Endoscope Reprocessor received 510(k) clearance from the US FDA.
  • In 2019, Fortive Corporation acquired ASP from Ethicon, Inc., a subsidiary of Johnson & Johnson. This acquisition enabled Fortive to portray an increased commitment to enhancing safe operations of hospitals and healthcare facilities worldwide.
  • In 2018, Cantel expanded its US headquarters in the United States to increase operational efficiencies and support market growth.
  • In 2018, Olympus Corporation launched OER-Mini tabletop endoscope reprocessor.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 31)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS OF THE STUDY
    1.3 MARKET SCOPE
           1.3.1 MARKET SEGMENTATION
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 MARKET STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 35)
    2.1 RESEARCH DATA
           FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 2 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                               FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION
           FIGURE 4 BOTTOM-UP APPROACH
           FIGURE 5 APPROACH 3: PARENT MARKET ANALYSIS [INFECTION CONTROL MARKET]
           FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
           FIGURE 7 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
           FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.4 ASSUMPTIONS FOR THE STUDY
    2.5 RISK ASSESSMENT/FACTOR ANALYSIS
           TABLE 1 RISKS
    2.6 COVID-19 ECONOMIC ASSESSMENT
    2.7 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
           FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY
           FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY

3 EXECUTIVE SUMMARY (Page No. - 47)
    FIGURE 11 ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021 VS. 2026 (USD BILLION)
    FIGURE 12 ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021 VS. 2026 (USD BILLION)
    FIGURE 13 ENDOSCOPE REPROCESSING MARKET, BY REGION, 2021 VS. 2026 (USD BILLION)

4 PREMIUM INSIGHTS (Page No. - 50)
    4.1 ENDOSCOPE REPROCESSING MARKET OVERVIEW
           FIGURE 14 THE RISING INCIDENCE OF TARGET DISEASES AND THE SUBSEQUENT INCREASE IN ENDOSCOPIC PROCEDURES IS A KEY FACTOR DRIVING MARKET GROWTH
    4.2 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET SHARE, BY PRODUCT (2020)
           FIGURE 15 THE HIGH-LEVEL DISINFECTANTS AND TEST STRIPS SEGMENT DOMINATED THE ASIA PACIFIC MARKET IN 2020
    4.3 GEOGRAPHICAL SNAPSHOT OF THE ENDOSCOPE REPROCESSING MARKET
           FIGURE 16 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 53)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 17 ENDOSCOPE REPROCESSING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing preference for endoscopic procedures
                    5.2.1.2 High risk of endoscope-associated infections
                    5.2.1.3 Growing geriatric population and the subsequent increase of endoscopic procedures
                    5.2.1.4 Increasing emphasis on improving reprocessing guidelines by healthcare authorities
           5.2.2 RESTRAINTS
                    5.2.2.1 Concerns related to the safety of reprocessed instruments
                    5.2.2.2 Adverse effects of chemical disinfectants
                    5.2.2.3 High cost of endoscopy procedures and limited reimbursements in developing countries
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing medical devices industry in emerging economies
                               FIGURE 18 MEDICAL DEVICES MARKET, 2016-2020 (USD BILLION)
           5.2.4 CHALLENGES
                    5.2.4.1 Preference for single-use endoscopes
                    5.2.4.2 Shortage of trained professionals
                    5.2.4.3 Lack of awareness associated with reprocessing methods
    5.3 SUPPLY CHAIN ANALYSIS
           FIGURE 19 DIRECT DISTRIBUTION—THE PREFERRED STRATEGY OF PROMINENT COMPANIES
    5.4 VALUE CHAIN ANALYSIS
           FIGURE 20 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES
    5.5 REGULATORY ANALYSIS
           TABLE 2 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING MEDICAL DEVICE REPROCESSING
           5.5.1 NORTH AMERICA
                    5.5.1.1 US
                               FIGURE 21 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR REPROCESSED MEDICAL DEVICES
                    5.5.1.2 Canada
                               TABLE 3 CANADA: REPROCESSING POLICIES OF SINGLE-USE MEDICAL DEVICES
           5.5.2 EUROPE
                    FIGURE 22 CE MARKING FOR REPROCESSED MEDICAL DEVICES
                    5.5.2.1 Germany
                    5.5.2.2 Rest of Europe
           5.5.3 ASIA PACIFIC (APAC)
                    5.5.3.1 Japan
                    5.5.3.2 Australia
                    5.5.3.3 Rest of APAC
           5.5.4 LATIN AMERICA
           5.5.5 MIDDLE EAST & AFRICA
    5.6 ECOSYSTEM ANALYSIS
           FIGURE 23 ENDOSCOPE REPROCESSING MARKET: ECOSYSTEM ANALYSIS
           5.6.1 ROLE IN THE ECOSYSTEM
                    FIGURE 24 KEY PLAYERS IN THE ENDOSCOPE REPROCESSING MARKET ECOSYSTEM
    5.7 PORTER’S FIVE FORCES ANALYSIS
           5.7.1 THREAT FROM NEW ENTRANTS
           5.7.2 BARGAINING POWER OF SUPPLIERS
           5.7.3 BARGAINING POWER OF BUYERS
           5.7.4 INTENSITY OF COMPETITIVE RIVALRY
           5.7.5 THREAT FROM SUBSTITUTES
    5.8 COVID-19 IMPACT ANALYSIS FOR THE ENDOSCOPE REPROCESSING MARKET
           FIGURE 25 PERCENTAGE OF ENDOSCOPY PROCEDURES/PER WEEK BEFORE AND DURING COVID-19
    5.9 TECHNOLOGY ANALYSIS
    5.10 PATENT ANALYSIS
           5.10.1 AUTOMATED ENDOSCOPE REPROCESSORS
    5.11 TRADE ANALYSIS
           5.11.1 IMPORT DATA FOR HS CODE 841920, BY COUNTRY, 2016–2020 (USD MILLION)
           5.11.2 EXPORT DATA FOR HS CODE 841920, BY COUNTRY, 2017–2019 (USD MILLION)
           5.11.3 EXPORT DATA FOR HS CODE 841920, BY COUNTRY, 2016–2020
           5.11.4 IMPORT DATA FOR HS CODE 841920, BY COUNTRY, 2016–2020
    5.12 PRICING ANALYSIS
                    TABLE 4 AVERAGE SELLING PRICES OF ENDOSCOPE REPROCESSING EQUIPMENT
                    TABLE 5 COST OF CONSUMABLES INVOLVED IN REPROCESSING ENDOSCOPES WITH MANUAL CLEANING PLUS AER
                    TABLE 6 TOTAL ESTIMATED COST FOR REPROCESSING ONE FLEXIBLE ENDOSCOPE
    5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
           5.13.1 REVENUE SHIFT & REVENUE POCKETS FOR ENDOSCOPE REPROCESSING MANUFACTURERS
                    FIGURE 26 REVENUE SHIFT FOR ENDOSCOPE REPROCESSING
    5.14 RANGES/ SCENARIOS
           5.14.1 ENDOSCOPE REPROCESSING MARKET
                    FIGURE 27 REALISTIC SCENARIO OF THE ENDOSCOPE REPROCESSING MARKET
                    FIGURE 28 PESSIMISTIC SCENARIO OF THE ENDOSCOPE REPROCESSING MARKET
                    FIGURE 29 OPTIMISTIC SCENARIO OF THE ENDOSCOPE REPROCESSING MARKET

6 ENDOSCOPE REPROCESSING MARKET, BY PRODUCT (Page No. - 81)
    6.1 INTRODUCTION
           TABLE 7 ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
           TABLE 8 ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
    6.2 HIGH-LEVEL DISINFECTANTS AND TEST STRIPS
           6.2.1 THE OUTBREAK OF CRE IS EXPECTED TO DRIVE THE DEMAND FOR HIGH-LEVEL DISINFECTANTS
                    TABLE 9 ENDOSCOPE REPROCESSING MARKET FOR HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, BY REGION, 2017–2019 (USD MILLION)
                    TABLE 10 ENDOSCOPE REPROCESSING MARKET FOR HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, BY REGION, 2020–2026 (USD MILLION)
    6.3 DETERGENTS & WIPES
           6.3.1 INCREASING EMPHASIS ON PRE-CLEANING METHODS TO PROPEL THE GROWTH OF THIS SEGMENT
                    TABLE 11 ENDOSCOPE REPROCESSING MARKET DETERGENTS & WIPES, BY REGION, 2017–2019 (USD MILLION)
                    TABLE 12 ENDOSCOPE REPROCESSING MARKET FOR DETERGENTS & WIPES, BY REGION, 2020–2026 (USD MILLION)
    6.4 AUTOMATED ENDOSCOPE REPROCESSORS (AERS)
           6.4.1 INCREASING EFFICIENCY OF AERS OVER MANUAL CLEANING LEADS TO THE GROWTH OF THIS SEGMENT
                    TABLE 13 MANUFACTURERS AND RESPECTIVE AER MODELS
                    TABLE 14 ENDOSCOPE REPROCESSING MARKET FOR AER, BY REGION, 2017–2019 (USD MILLION)
                    TABLE 15 ENDOSCOPE REPROCESSING MARKET FOR AER, BY REGION, 2020–2026 (USD MILLION)
           6.4.2 AUTOMATED ENDOSCOPE REPROCESSORS, BY PORTABILITY
                    6.4.2.1 Introduction
                               TABLE 16 ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2017–2019 (USD MILLION)
                               TABLE 17 ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2020–2026 (USD MILLION)
                    6.4.2.2 Standalone AER
                               TABLE 18 ENDOSCOPE REPROCESSING MARKET FOR STANDALONE AER, BY REGION, 2017–2019 (USD MILLION)
                               TABLE 19 ENDOSCOPE REPROCESSING MARKET FOR STANDALONE AER, BY REGION, 2020–2026 (USD MILLION)
                    6.4.2.3 Portable Automated Endoscope Reprocessors
                               TABLE 20 ENDOSCOPE REPROCESSING MARKET FOR PORTABLE AER, BY REGION, 2017–2019 (USD MILLION)
                               TABLE 21 ENDOSCOPE REPROCESSING MARKET FOR PORTABLE AER, BY REGION, 2020–2026 (USD MILLION)
           6.4.3 AUTOMATED ENDOSCOPE REPROCESSORS, BY TYPE
                    TABLE 22 ENDOSCOPE REPROCESSING MARKET FOR AER, BY TYPE, 2017–2019 (USD MILLION)
                    TABLE 23 ENDOSCOPE REPROCESSING MARKET FOR AER, BY TYPE, 2020–2026 (USD MILLION)
                    6.4.3.1 Single-basin Automated Endoscope Reprocessors
                    6.4.3.2 Double-basin Automated Endoscope Reprocessors
    6.5 ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS
           6.5.1 STRINGENT GUIDELINES FOR STORAGE AND TRANSPORTATION OF REPROCESSED ENDOSCOPES TO PROPEL GROWTH OF THIS SEGMENT
                    TABLE 24 ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS OFFERED BY MARKET PLAYERS
                    TABLE 25 ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS, BY REGION, 2017–2019 (USD MILLION)
                    TABLE 26 ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS, BY REGION, 2020–2026 (USD MILLION)
    6.6 ENDOSCOPE TRACKING SYSTEMS
           6.6.1 RISING FOCUS TOWARDS EFFECTIVE REPROCESSING TO DRIVE THE GROWTH OF THIS SEGMENT
                    TABLE 27 ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE TRACKING SOLUTIONS, BY REGION, 2017–2019 (USD MILLION)
                    TABLE 28 ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE TRACKING SOLUTIONS, BY REGION, 2020–2026 (USD MILLION)
    6.7 OTHER PRODUCTS
           TABLE 29 OTHER PRODUCTS OFFERED BY MANUFACTURERS
           TABLE 30 ENDOSCOPE REPROCESSING MARKET FOR OTHER PRODUCTS, BY REGION, 2017–2019 (USD MILLION)
           TABLE 31 ENDOSCOPE REPROCESSING MARKET FOR OTHER PRODUCTS, BY REGION, 2020–2026 (USD MILLION)

7 ENDOSCOPE REPROCESSING MARKET, BY END USER (Page No. - 100)
    7.1 INTRODUCTION
           TABLE 32 ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2019 (USD MILLION)
           TABLE 33 ENDOSCOPE REPROCESSING MARKET, BY END USER, 2020–2026 (USD MILLION)
    7.2 HOSPITALS
           7.2.1 LARGE PATIENT VOLUME IN HOSPITALS TO LEAD TO THE INCREASING DEMAND FOR ENDOSCOPE REPROCESSING PRODUCTS
                    TABLE 34 ENDOSCOPE REPROCESSING MARKET FOR HOSPITALS, BY REGION, 2017–2019 (USD MILLION)
                    TABLE 35 ENDOSCOPE REPROCESSING MARKET FOR HOSPITALS, BY REGION, 2020–2026 (USD MILLION)
    7.3 AMBULATORY SURGERY CENTERS AND CLINICS
           7.3.1 COST-EFFECTIVENESS OF ASCS AND CLINICS TO DRIVE THE GROWTH OF THIS END-USER SEGMENT
                    TABLE 36 NUMBER OF MEDICARE-CERTIFIED ASCS IN THE US, 2013–2017
                    TABLE 37 ENDOSCOPE REPROCESSING MARKET FOR ASCS AND CLINICS, BY REGION, 2017–2019 (USD MILLION)
                    TABLE 38 ENDOSCOPE REPROCESSING MARKET FOR ASCS AND CLINICS, BY REGION, 2020–2026 (USD MILLION)
    7.4 OTHER END USERS
           TABLE 39 ENDOSCOPE REPROCESSING MARKET FOR OTHER END USERS, BY REGION, 2017–2019 (USD MILLION)
           TABLE 40 ENDOSCOPE REPROCESSING MARKET FOR OTHER END USERS, BY REGION, 2020–2026 (USD MILLION)

8 ENDOSCOPE REPROCESSING MARKET, BY REGION (Page No. - 108)
    8.1 INTRODUCTION
           TABLE 41 ENDOSCOPE REPROCESSING MARKET, BY REGION, 2017–2019 (USD MILLION)
           TABLE 42 ENDOSCOPE REPROCESSING MARKET, BY REGION, 2020–2026 (USD MILLION)
    8.2 NORTH AMERICA
           FIGURE 30 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET SNAPSHOT
           TABLE 43 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
           TABLE 44 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
           TABLE 45 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
           TABLE 46 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
           TABLE 47 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2017–2019 (USD MILLION)
           TABLE 48 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2020–2026 (USD MILLION)
           TABLE 49 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2019 (USD MILLION)
           TABLE 50 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2020–2026 (USD MILLION)
           8.2.1 US
                    8.2.1.1 Favorable reimbursement scenario to propel market growth in the US
                               TABLE 51 MEDICARE NATIONAL AVERAGE COVERAGE FOR OUTPATIENT PROCEDURES, 2021
                               TABLE 52 US ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                               TABLE 53 US ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                               TABLE 54 US: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2017–2019 (USD MILLION)
                               TABLE 55 US: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2020–2026 (USD MILLION)
                               TABLE 56 US: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2019 (USD MILLION)
                               TABLE 57 US: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2020–2026 (USD MILLION)
           8.2.2 CANADA
                    8.2.2.1 The high prevalence of HAIs drives the market growth for endoscope reprocessing products in Canada
                               TABLE 58 CANADA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                               TABLE 59 CANADA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                               TABLE 60 CANADA: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2017–2019 (USD MILLION)
                               TABLE 61 CANADA: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2020–2026 (USD MILLION)
                               TABLE 62 CANADA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2019 (USD MILLION)
                               TABLE 63 CANADA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2020–2026 (USD MILLION)
    8.3 EUROPE
           TABLE 64 EUROPE: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
           TABLE 65 EUROPE: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
           TABLE 66 EUROPE ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
           TABLE 67 EUROPE ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
           TABLE 68 EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2017–2019 (USD MILLION)
           TABLE 69 EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2020–2026 (USD MILLION)
           TABLE 70 EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2019 (USD MILLION)
           TABLE 71 EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2020–2026 (USD MILLION)
           8.3.1 GERMANY
                    8.3.1.1 The increasing number of surgical procedures is expected to drive the market growth for endoscope reprocessors in Germany
                               TABLE 72 GERMANY: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
                               TABLE 73 GERMANY ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                               TABLE 74 GERMANY ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                               TABLE 75 GERMANY ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2017–2019 (USD MILLION)
                               TABLE 76 GERMANY ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2020–2026 (USD MILLION)
                               TABLE 77 GERMANY ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2019 (USD MILLION)
                               TABLE 78 GERMANY ENDOSCOPE REPROCESSING MARKET, BY END USER, 2020–2026 (USD MILLION)
           8.3.2 UK
                    8.3.2.1 Increasing use of endoscopy procedures to drive market growth in the UK
                               FIGURE 31 MEAN PERCENTAGE CHANGE IN ENDOSCOPE PROCEDURE NUMBERS BETWEEN 2017 AND 2019
                               TABLE 79 UK: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                               TABLE 80 UK: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                               TABLE 81 UK: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2017–2019 (USD MILLION)
                               TABLE 82 UK: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2020–2026 (USD MILLION)
                               TABLE 83 UK: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2019 (USD MILLION)
                               TABLE 84 UK: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2020–2026 (USD MILLION)
           8.3.3 FRANCE
                    8.3.3.1 Increasing prevalence of cancer to support market growth in France
                               TABLE 85 FRANCE: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
                               TABLE 86 FRANCE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                               TABLE 87 FRANCE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                               TABLE 88 FRANCE: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2017–2019 (USD MILLION)
                               TABLE 89 FRANCE: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2020–2026 (USD MILLION)
                               TABLE 90 FRANCE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2019 (USD MILLION)
                               TABLE 91 FRANCE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2020–2026 (USD MILLION)
           8.3.4 ITALY
                    8.3.4.1 Growing geriatric population in Italy to support market growth for various endoscopic procedures
                               TABLE 92 ITALY: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
                               TABLE 93 ITALY: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                               TABLE 94 ITALY: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                               TABLE 95 ITALY: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2017–2019 (USD MILLION)
                               TABLE 96 ITALY: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2020–2026 (USD MILLION)
                               TABLE 97 ITALY: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2019 (USD MILLION)
                               TABLE 98 ITALY: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2020–2026 (USD MILLION)
           8.3.5 SPAIN
                    8.3.5.1 Developing healthcare infrastructure to support market growth for endoscopic procedures in Spain
                               TABLE 99 SPAIN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                               TABLE 100 SPAIN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                               TABLE 101 SPAIN: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2017–2019 (USD MILLION)
                               TABLE 102 SPAIN: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2020–2026 (USD MILLION)
                               TABLE 103 SPAIN: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2019 (USD MILLION)
                               TABLE 104 SPAIN: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2020–2026 (USD MILLION)
           8.3.6 REST OF EUROPE (ROE)
                    TABLE 105 ROE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                    TABLE 106 ROE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                    TABLE 107 ROE: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2017–2019 (USD MILLION)
                    TABLE 108 ROE: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2020–2026 (USD MILLION)
                    TABLE 109 ROE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2019 (USD MILLION)
                    TABLE 110 ROE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2020–2026 (USD MILLION)
    8.4 ASIA PACIFIC
           FIGURE 32 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET SNAPSHOT
           TABLE 111 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
           TABLE 112 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
           TABLE 113 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
           TABLE 114 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
           TABLE 115 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2017–2019 (USD MILLION)
           TABLE 116 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2020–2026 (USD MILLION)
           TABLE 117 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2019 (USD MILLION)
           TABLE 118 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2020–2026 (USD MILLION)
           8.4.1 JAPAN
                    8.4.1.1 Increasing use of endoscopes to drive the market growth in Japan
                               TABLE 119 JAPAN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                               TABLE 120 JAPAN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                               TABLE 121 JAPAN: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2017–2019 (USD MILLION)
                               TABLE 122 JAPAN: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2020–2026 (USD MILLION)
                               TABLE 123 JAPAN: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2019 (USD MILLION)
                               TABLE 124 JAPAN: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2020–2026 (USD MILLION)
           8.4.2 CHINA
                    8.4.2.1 The rising prevalence of cancer in China is expected to lead to a demand for endoscopic procedures
                               TABLE 125 CHINA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
                               TABLE 126 CHINA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                               TABLE 127 CHINA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                               TABLE 128 CHINA: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2017–2019 (USD MILLION)
                               TABLE 129 CHINA: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2020–2026 (USD MILLION)
                               TABLE 130 CHINA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2019 (USD MILLION)
                               TABLE 131 CHINA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2020–2026 (USD MILLION)
           8.4.3 INDIA
                    8.4.3.1 Developing healthcare infrastructure to support market growth in India
                               TABLE 132 INDIA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                               TABLE 133 INDIA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                               TABLE 134 INDIA: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2017–2019 (USD MILLION)
                               TABLE 135 INDIA: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2020–2026 (USD MILLION)
                               TABLE 136 INDIA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2019 (USD MILLION)
                               TABLE 137 INDIA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2020–2026 (USD MILLION)
           8.4.4 REST OF ASIA PACIFIC (ROAPAC)
                    TABLE 138 INCIDENCE OF CANCER IN ROAPAC COUNTRIES
                    TABLE 139 ROAPAC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                    TABLE 140 ROAPAC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                    TABLE 141 ROAPAC: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2017–2019 (USD MILLION)
                    TABLE 142 ROAPAC: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2020–2026 (USD MILLION)
                    TABLE 143 ROAPAC: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2019 (USD MILLION)
                    TABLE 144 ROAPAC: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2020–2026 (USD MILLION)
    8.5 REST OF THE WORLD (ROW)
           TABLE 145 ROW: ENDOSCOPE REPROCESSING MARKET, BY REGION, 2017–2019 (USD MILLION)
           TABLE 146 ROW: ENDOSCOPE REPROCESSING MARKET, BY REGION, 2020–2026 (USD MILLION)
           TABLE 147 ROW ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
           TABLE 148 ROW ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
           TABLE 149 ROW: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2017–2019 (USD MILLION)
           TABLE 150 ROW: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2020–2026 (USD MILLION)
           TABLE 151 ROW: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2019 (USD MILLION)
           TABLE 152 ROW: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2020–2026 (USD MILLION)
           8.5.1 LATIN AMERICA
                    8.5.1.1 Rising prevalence of infections due to endoscopy-related procedures to support market growth
                               TABLE 153 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                               TABLE 154 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                               TABLE 155 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2017–2019 (USD MILLION)
                               TABLE 156 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2020–2026 (USD MILLION)
                               TABLE 157 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2019 (USD MILLION)
                               TABLE 158 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2020–2026 (USD MILLION)
           8.5.2 MIDDLE EAST & AFRICA
                    8.5.2.1 The introduction of regulatory frameworks for the reprocessing of medical equipment is expected to drive the market growth in the MEA
                               TABLE 159 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                               TABLE 160 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                               TABLE 161 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2017–2019 (USD MILLION)
                               TABLE 162 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET FOR AER, BY PORTABILITY, 2020–2026 (USD MILLION)
                               TABLE 163 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2019 (USD MILLION)
                               TABLE 164 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2020–2026 (USD MILLION)

9 COMPETITIVE LANDSCAPE (Page No. - 173)
    9.1 OVERVIEW
    9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
           TABLE 165 OVERVIEW OF STRATEGIES ADOPTED BY KEY ENDOSCOPE REPROCESSING PRODUCT MANUFACTURERS
    9.3 REVENUE ANALYSIS
           FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN THE ENDOSCOPE REPROCESSING MARKET
    9.4 MARKET SHARE ANALYSIS
           FIGURE 34 ENDOSCOPE REPROCESSING MARKET SHARE ANALYSIS, 2020
           TABLE 166 ENDOSCOPE REPROCESSING MARKET: DEGREE OF COMPETITION
    9.5 COMPANY EVALUATION QUADRANT (MAJOR PLAYERS)
           9.5.1 STARS
           9.5.2 EMERGING LEADERS
           9.5.3 PERVASIVE PLAYERS
           9.5.4 PARTICIPANTS
                    FIGURE 35 VENDOR DIVE: ENDOSCOPE REPROCESSING MARKET
    9.6 COMPETITIVE LEADERSHIP MAPPING (START-UPS AND SMES)
           9.6.1 PROGRESSIVE COMPANIES
           9.6.2 STARTING BLOCKS
           9.6.3 RESPONSIVE COMPANIES
           9.6.4 DYNAMIC COMPANIES
                    FIGURE 36 ENDOSCOPE REPROCESSING MARKET: VENDOR DIVE MATRIX FOR SMES AND START-UPS, 2020
    9.7 COMPANY FOOTPRINT
           TABLE 167 COMPANY FOOTPRINT
           TABLE 168 COMPANY PRODUCT FOOTPRINT
           TABLE 169 COMPANY GEOGRAPHICAL FOOTPRINT
    9.8 COMPETITIVE SCENARIO AND TRENDS
           9.8.1 DEALS
                    TABLE 170 DEALS, JANUARY 2018-JUNE 2021
           9.8.2 PRODUCT LAUNCHES & APPROVALS
                    TABLE 171 PRODUCT LAUNCHES & APPROVALS, JANUARY 2018-JUNE 2021
           9.8.3 EXPANSIONS
                    TABLE 172 EXPANSIONS, JANUARY 2018-JUNE 2021

10 COMPANY PROFILES (Page No. - 187)
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
     10.1 KEY PLAYERS
             10.1.1 CANTEL MEDICAL
                       TABLE 173 CANTEL MEDICAL: BUSINESS OVERVIEW
                       FIGURE 37 CANTEL MEDICAL: COMPANY SNAPSHOT (2020)
             10.1.2 ADVANCED STERILIZATION PRODUCTS
                       TABLE 174 ADVANCED STERILIZATION PRODUCTS: BUSINESS OVERVIEW
                       FIGURE 38 FORTIVE: COMPANY SNAPSHOT (2020)
             10.1.3 OLYMPUS CORPORATION
                       TABLE 175 OLYMPUS CORPORATION: BUSINESS OVERVIEW
                       FIGURE 39 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2020)
             10.1.4 ECOLAB
                       TABLE 176 ECOLAB: BUSINESS OVERVIEW
                       FIGURE 40 ECOLAB: COMPANY SNAPSHOT (2020)
             10.1.5 STERIS
                       TABLE 177 STERIS: BUSINESS OVERVIEW
                       FIGURE 41 STERIS: COMPANY SNAPSHOT (2021)
             10.1.6 GETINGE AB
                       TABLE 178 GETINGE AB: BUSINESS OVERVIEW
                       FIGURE 42 GETINGE AB: COMPANY SNAPSHOT (2020)
             10.1.7 WASSENBURG MEDICAL (A MEMBER OF HOYA)
                       TABLE 179 WASSENBURG MEDICAL: BUSINESS OVERVIEW
                       FIGURE 43 HOYA: COMPANY SNAPSHOT (2021)
             10.1.8 CONMED CORPORATION
                       TABLE 180 CONMED CORPORATION: BUSINESS OVERVIEW
                       FIGURE 44 CONMED CORPORATION: COMPANY SNAPSHOT (2020)
             10.1.9 BELIMED AG (A METALL ZUG GROUP COMPANY)
                       TABLE 181 BELIMED AG: BUSINESS OVERVIEW
                       FIGURE 45 METALL ZUG: COMPANY SNAPSHOT (2020)
             10.1.10 ENDO-TECHNIK W. GRIESAT GMBH
                       TABLE 182 ENDO-TECHNIK W. GRIESAT GMBH: BUSINESS OVERVIEW
                       FIGURE 46 CREO MEDICAL: COMPANY SNAPSHOT (2020)
             10.1.11 CUSTOM ULTRASONICS
                       TABLE 183 CUSTOM ULTRASONICS: BUSINESS OVERVIEW
             10.1.12 STEELCO S.P.A
                       TABLE 184 STEELCO S.P.A: BUSINESS OVERVIEW
             10.1.13 BES HEALTHCARE (A DIVISION OF BES REHAB LTD)
                       TABLE 185 BES HEALTHCARE: BUSINESS OVERVIEW
             10.1.14 ARC HEALTHCARE SOLUTIONS
                       TABLE 186 ARC HEALTHCARE SOLUTIONS: BUSINESS OVERVIEW
             10.1.15 METREX RESEARCH, LLC
                       TABLE 187 METREX RESEARCH. LLC: BUSINESS OVERVIEW
     10.2 OTHER PLAYERS
             10.2.1 RICHARD WOLF GMBH
                       TABLE 188 RICHARD WOLF GMBH: BUSINESS OVERVIEW
             10.2.2 MEDALKAN
                       TABLE 189 MEDALKAN: BUSINESS OVERVIEW
             10.2.3 MICRO-SCIENTIFIC, LLC
                       TABLE 190 MICRO-SCIENTIFIC, LLC: BUSINESS OVERVIEW
             10.2.4 BORER CHEMIE AG
                       TABLE 191 BORER CHEMIE AG: BUSINESS OVERVIEW
             10.2.5 TUTTNAUER
                       TABLE 192 TUTTNAUER: BUSINESS OVERVIEW
             10.2.6 ATMS
                       TABLE 193 ATMS: BUSINESS OVERVIEW
             10.2.7 SUMMIT IMAGING, INC.
                       TABLE 194 SUMMIT IMAGING, INC.: BUSINESS OVERVIEW
             10.2.8 MEDONICA CO. LTD
                       TABLE 195 MEDONICA CO. LTD: BUSINESS OVERVIEW
             10.2.9 SHINVA MEDICAL INSTRUMENT CO., LTD
                       TABLE 196 SHINVA MEDICAL INSTRUMENT CO., LTD: BUSINESS OVERVIEW
             10.2.10 MEDICAL DEVICES GROUP SRL
                       TABLE 197 MEDICAL DEVICES GROUP SRL: BUSINESS OVERVIEW

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

11 APPENDIX (Page No. - 233)
     11.1 INSIGHTS FROM INDUSTRY EXPERTS
     11.2 DISCUSSION GUIDE
     11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     11.4 AVAILABLE CUSTOMIZATIONS
     11.5 RELATED REPORTS
     11.6 AUTHOR DETAILS

The study involved four major activities to estimate the current size of the endoscope reprocessing market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for this study.

Primary Research

Several stakeholders such as endoscope reprocessing manufacturers, vendors, distributors, and physicians from hospitals and clinics were consulted for this report. The demand side of this market is characterized by increasing preference for endoscopic procedures, high risk of endoscope-associated infections, growing geriatric population and the subsequent increase of endoscopic procedures, and increasing emphasis on improving reprocessing guidelines by healthcare facilities. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Endoscope Reprocessing Market  Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the endoscope reprocessing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the endoscope reprocessing industry.

Report Objectives

  • To define, describe, and forecast the endoscope reprocessing market based on product, end user, and region.
  • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, and opportunities, COVID-19 Impact Analysis)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall endoscope reprocessing market
  • To analyse market opportunities for stakeholders and provide details of the competitive landscape for key players.
  • To forecast the size of the market segments in four geographical regions, namely, North America, Europe, the Asia Pacific, and Rest of the World.
  • To profile the key players and comprehensively analyse their product portfolios, market positions, and core competencies.
  • To track and analyse competitive developments such as product launches and approvals, deals and expansions in the endoscope reprocessing market.

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

  • Geographic Analysis: Further breakdown of the endoscope reprocessing market into specific countries/regions in the Rest of Europe, Rest of Asia Pacific, Middle East & African, and Latin American countries
  • Company Information: Detailed analysis and profiling of additional market players (up to 5) inclusive of:
    • Business Overview
    • Financial Information
    • Product Portfolio
    • Developments (last three years)
COVID-19

Get in-depth analysis of the COVID-19 impact on the Endoscope Reprocessing Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Endoscope Reprocessing Market

Request For Special Pricing
Report Code
MD 5654
Published ON
Jul, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Endoscope Reprocessing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home